Autolus Therapeutics Plc (AUTL)
1.63
+0.04
(+2.52%)
USD |
NASDAQ |
May 15, 16:00
1.60
-0.03
(-1.84%)
After-Hours: 20:00
Autolus Therapeutics Shareholders Equity (Quarterly) : 108.83M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 29.50M |
| Mereo BioPharma Group Plc | 34.05M |
| Cellectis SA | 59.92M |
| Akari Therapeutics Plc | 28.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 527.06M |
| Total Liabilities (Quarterly) | 418.24M |
| Debt to Equity Ratio | 3.392 |
| Current Ratio | 5.758 |
| Net Debt Paydown Yield | -3.92% |